<DOC>
	<DOCNO>NCT02657993</DOCNO>
	<brief_summary>The purpose study determine whether hypnosis efficacious reduce musculoskeletal pain breast cancer survivor take aromatase inhibitor , , whether hypnosis help survivor adherent medication regimen .</brief_summary>
	<brief_title>Hypnosis Reduce Aromatase Inhibitor Pain Improve Adherence</brief_title>
	<detailed_description>The primary purpose study evaluate efficacy hypnosis reduce musculoskeletal pain ( MSP ) woman take aromatase inhibitor ( AIs ) breast cancer . Research indicate AIs associate musculoskeletal pain 61 % breast cancer survivor . AI-associated MSP include joint pain wrist , hand , knee ; carpal tunnel syndrome trigger finger ; decrease grip strength , morning stiffness , general muscle pain . MSP lead difficulty perform daily activity reduce quality life breast cancer survivor . This pain aversive , also associate non-adherence prescribed , daily AI regimen . In study , AI non-adherence estimate high 50 % . At present time , `` gold standard '' treatment AI-associated MSP . What need intervention : reduces breast cancer survivor ' MSP help adherent prescribed AI regimen , side-effects , place large time financial burden survivor , teach survivor practice . Hypnosis , mind-body intervention , widely demonstrate reduce pain . In fact , analgesia perhaps best known effect hypnosis . Meta-analyses consistently support efficacy hypnosis pain control , include chronic pain . Hypnosis also long tradition cancer symptom management , especially pain reduction . Hypnosis define agreement person designate hypnotist ( e.g. , health care professional ) person designate client patient participate psychotherapeutic technique base hypnotist provide suggestion change sensation , perception , cognition , affect , mood , behavior . This study examine whether hypnosis helpful reduce breast cancer survivor ' AI-related MSP improve adherence prescribe AI regimen . This study also examine whether hypnosis intervention cost effective . To answer question , randomize clinical trial compare hypnosis ( three session ) non-hypnosis , attention control , empathic listen condition ( three session ) . For intervention , first session approximately 40 minute , session 2 3 approximately 30 minute . Both intervention deliver face-to-face , doctoral-level psychology professional . All participant take AIs breast cancer , experience musculoskeletal pain since start AIs ( ≥3 10 point scale ) , randomize one two intervention group . Study participant ask complete measure pain , AI adherence , behavioral psychosocial measure course 12-month period . The follow-up assessment evaluate clinical efficacy cost-effectiveness hypnosis versus professional attention . Overall , project critical step towards reduce struggle breast cancer survivor experience AI-related MSP , associate non-adherence . By reduce MSP improve AI adherence , hypnosis intervention test potential improve quality life well-being .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Musculoskeletal Pain</mesh_term>
	<mesh_term>Aromatase Inhibitors</mesh_term>
	<criteria>Female Diagnosed Stage 0III hormonereceptor positive breast cancer Taking thirdgeneration aromatase inhibitor ( AI ) ( e.g. , anastrozole ( Arimidex ) , letrozole ( Femara ) , exemestane ( Aromasin ) ) least 3 month leave AI prescription complete study assessment ( e.g. , least one year leave AIs ) Experiencing ongoing pain and/or stiffness one joint , start worsen initiation AI therapy , baseline bad pain score past week Brief Pain InventoryShort Form ( BPISF ) ≥ 3 0 10 scale Be age 18 Speak read English ( allow participation study intervention session ) Consent study Be willing randomized experimental condition . Inflammatory , metabolic neuropathic arthropathy time recruitment Fibromyalgia Past cancer . Patients exclude ever diagnose cancer ( include DCIS/LCIS ) prior breast cancer present course AIs prescribed . However , patient eligible history nonmetastatic , nonmelanotomous skin cancer Metastatic ( Stage IV ) breast cancer , treatment outcome typically follow different course Bone fracture/surgery extremity precede 6 month Nonsteroidal joint injection within last 3 month . Current use corticosteroid , define oral , intravenous ( IV ) , injection corticosteroids past 4 week Regular use narcotic . Patients exclude due presence follow psychiatric condition : dementia , psychosis , current mania uncontrolled major depressive disorder , addictive disorder current intoxication . In rare instance presence comorbidity fall mention exclusion criterion , clinically determine significantly interfere patient 's ability participate study ( e.g. , cognitive impairment )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Breast Neoplasms</keyword>
	<keyword>Aromatase Inhibitors</keyword>
	<keyword>Musculoskeletal Pain</keyword>
	<keyword>Hypnosis</keyword>
	<keyword>Medication Adherence</keyword>
	<keyword>Cost-Benefit Analysis</keyword>
	<keyword>Treatment Outcomes</keyword>
</DOC>